Back to Emerging Issues in Oncology - Updates from ASBMT (2019)
Emerging Issues in Oncology - Updates from ASBMT (2019)

Emerging Issues in Oncology - Updates from ASBMT (2019)

HOPA is pleased to present the second of a five-webinar series, which will review key findings from clinical and translational research, and data presented at national oncology meetings.

This BCOP webinar will highlight novel and innovative abstracts or presentations featured at the 2019 Transplant and Cellular Therapy (TCT) Conference in Houston, TX. February 20-24, 2019.  Research included in this module will focus on acute/chronic leukemia, myelodysplastic syndrome, and multiple myeloma patient populations undergoing allogeneic and autologous hematopoietic cell transplantation (HCT) or cellular therapy.  Particularly, this presentation will focus on novel conditioning regimens, impact of post-HCT therapy and advances in treating graft versus host disease (GVHD). 

Product Details

Speaker: Katie Culos, PharmD BCOP

Dr. Culos is a Board Certified Oncology Pharmacist practicing since 2013 at Vanderbilt University Medical Center in Adult Cellular Therapy. She received her Doctorate of Pharmacy from the University of Illinois at Chicago College of Pharmacy and completed her Pharmacy Practice and Oncology Pharmacy Residency at University of Illinois Hospital & Health Sciences System. Outside of her clinical duties at Vanderbilt she serves as the Program Director of the Oncology Pharmacy Residency, works on the Antimicrobial and Immune Effector Cell Subcommittees and is the current past chair of the American Society of Bone Marrow Transplant Pharmacy Special Interest Group Research Working Committee.

  • List Price: $70.00 USD
  • Member Price: $40.00 USD
Join and Save!
Log into see if you qualify for a lower price.
HOPA members save $30.00 USD or more!
Become a member